Funding Rounds
Enara Bio

Enara Bio Series B Round, October 2024

Enara Bio

TCR-based immunotherapies developer targeting novel dark antigens for cancer patients.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $32.50M

Raised Date: 2024-10-03

Investors